Show Summaries | Hide Summaries
Tue, Jun. 9, 5:37 PM
Thu, May 7, 5:12 PM
May 19, 2014, 12:45 PM| Comment!
Feb. 7, 2014, 12:25 PM
Nov. 8, 2013, 12:53 PM| Comment!
Nov. 27, 2012, 10:51 AMAceto Pharmaceutical (ACET +2.1%) gets a boost today from what appears to be a delayed reaction to yesterday's launch of its generic Clindamycin Palmitate Hydrochloride for Oral Solution, an FDA approved generic version of Pfizer's (PFE -0.6%) Cleocin Pediatric. U.S. market sales for Clindamycin Palmitate Hydrochloride - which is an antibiotic that is used to treat serious bacterial infections - were approximately $59M for the twelve months ended June 30. | Comment!
ACET vs. ETF Alternatives
Aceto Corp is engaged in the marketing, sales and distribution of finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals.
Other News & PR